Nate Larson
6Patents
4h-index
4Co-inventors
42Inventor score
Filing activity: Apr 27, 2018 → Jan 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10836787B2 | Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate | Emerging Cross-Sectional Technologies | 28 | Active |
| US10675296B2 | Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections | Human Necessities | 27 | Active |
| US11266681B2 | Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections | Human Necessities | 23 | Active |
| US11597742B2 | Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate | Emerging Cross-Sectional Technologies | 17 | Active |
| US12030906B2 | Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate | Emerging Cross-Sectional Technologies | 4 | Active |
| US11975017B2 | Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections | Human Necessities | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.